Annexon Bioscience is a clinical-stage biopharmaceutical company focused on developing novel complement medicines to treat autoimmune, neurodegenerative, and ophthalmic disorders. The company's pipeline includes product candidates like ANX005, ANX007, and ANX009, designed to block C1q activity and the classical complement pathway through various administration methods. Annexon employs a disciplined, biomarker-driven approach to enhance its portfolio's technical success.
Annexon Biosciences is seeking a Senior Director of Clinical Development to lead the clinical strategy and execution of various development programs, ensuring scientific rigor, regulatory compliance, and corporate alignment. This role involves end-to-end design and execution of clinical trials from Phase I to Phase III, collaborating with cross-functional teams and leading regulatory submissions. The ideal candidate will be a strategic leader with expertise in clinical trial design, regulatory affairs, and a proven ability to manage complex programs in a fast-paced environment.
Annexon Bioscience is a clinical-stage biopharmaceutical company focused on developing novel complement medicines to treat autoimmune, neurodegenerative, and ophthalmic disorders. The company's pipeline includes product candidates like ANX005, ANX007, and ANX009, designed to block C1q activity and the classical complement pathway through various administration methods. Annexon employs a disciplined, biomarker-driven approach to enhance its portfolio's technical success.
Seaport Therapeutics